Livdelzi 10 MG (equivalent to 14.1 MG seladelpar lysine) Oral Capsule
- RxCUI
- 2690881
- RxNorm name
- Livdelzi 10 MG (equivalent to 14.1 MG seladelpar lysine) Oral Capsule
- Display name
- Livdelzi 10 MG (equivalent to 14.1 MG seladelpar lysine) Oral Capsule
- Full name
- Livdelzi 10 MG (equivalent to 14.1 MG seladelpar lysine) Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Livdelzi | SELADELPAR LYSINE | Gilead Sciences, Inc | 89f79d98-135c-40b2-a585-6996c04e599c | 2026-02-03 | Warnings, Adverse reactions | 2690881 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 89f79d98-135c-40b2-a585-6996c04e599c | Livdelzi 10 MG Oral Capsule [PSN] · seladelpar 10 MG Oral Capsule [Livdelzi] [SBD] · Livdelzi 10 MG (equivalent to 14.1 MG seladelpar lysine) Oral Capsule [SY] | 3 | 3 | These highlights do not include all the information needed to use LIVDELZI safely and effectively. See full prescribing information for LIVDELZI. LIVDELZI ® (seladelpar) capsules, for oral use Initial U.S. Approval: 2024 | 20260203 |